Progressive multiple sclerosis: from pathogenic mechanisms to treatment

J Correale, MI Gaitán, MC Ysrraelit, MP Fiol - Brain, 2017 - academic.oup.com
During the past decades, better understanding of relapsing-remitting multiple sclerosis
disease mechanisms have led to the development of several disease-modifying therapies …

Association between pathological and MRI findings in multiple sclerosis

M Filippi, W Brück, D Chard, F Fazekas… - The Lancet …, 2019 - thelancet.com
Pathological evaluation is the gold standard for identifying processes related to multiple
sclerosis that explain disease manifestations, and for guiding the development of new …

Thalamic atrophy in multiple sclerosis: a magnetic resonance imaging marker of neurodegeneration throughout disease

CJ Azevedo, SY Cen, S Khadka, S Liu… - Annals of …, 2018 - Wiley Online Library
Objective Thalamic volume is a candidate magnetic resonance imaging (MRI)‐based
marker associated with neurodegeneration to hasten development of neuroprotective …

Magnetic resonance imaging in multiple sclerosis

CC Hemond, R Bakshi - Cold Spring …, 2018 - perspectivesinmedicine.cshlp.org
Since its technical development in the early 1980s, magnetic resonance imaging (MRI) has
quickly been adopted as an essential tool in supporting the diagnosis, longitudinal …

Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration

M Tonietto, E Poirion, A Lazzarotto, V Ricigliano… - Brain, 2023 - academic.oup.com
In multiple sclerosis, spontaneous remyelination is generally incomplete and heterogeneous
across patients. A high heterogeneity in remyelination may also exist across lesions within …

Deep grey matter injury in multiple sclerosis: a NAIMS consensus statement

D Ontaneda, PC Raza, KR Mahajan, DL Arnold… - 2021 - academic.oup.com
Although multiple sclerosis has traditionally been considered a white matter disease,
extensive research documents the presence and importance of grey matter injury including …

Role of oligodendrocyte dysfunction in demyelination, remyelination and neurodegeneration in multiple sclerosis

AO Dulamea - Multiple Sclerosis: Bench to Bedside: Global …, 2017 - Springer
Oligodendrocytes (OLs) are the myelinating cells of the central nervous system (CNS) during
development and throughout adulthood. They result from a complex and well controlled …

Localized atrophy of the thalamus and slowed cognitive processing speed in MS patients

N Bergsland, R Zivadinov, MG Dwyer… - Multiple Sclerosis …, 2016 - journals.sagepub.com
Background: Deep gray matter (DGM) atrophy is common in multiple sclerosis (MS), but no
studies have investigated surface-based structure changes over time with respect to healthy …

Diagnosis of progressive multiple sclerosis from the imaging perspective: a review

M Filippi, P Preziosa, F Barkhof, DT Chard… - JAMA …, 2021 - jamanetwork.com
Importance Although magnetic resonance imaging (MRI) is useful for monitoring disease
dissemination in space and over time and excluding multiple sclerosis (MS) mimics, there …

Thalamic injury and cognition in multiple sclerosis

M Amin, D Ontaneda - Frontiers in Neurology, 2021 - frontiersin.org
Multiple sclerosis (MS) produces demyelination and degeneration in both gray and white
matter. Both cortical and deep gray matter injury is observed during the course of MS …